• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 3 of 100
How pharma giant AbbVie holds leaders accountable for culture 
Workplace CultureHow pharma giant AbbVie holds leaders accountable for culture 
By Ted Kitterman and Great Place To WorkOctober 9, 2025
Mark Cuban sits on a white chair in front of a purple background, speaking into a microphone.
North AmericaMark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’
By Sasha RogelbergOctober 2, 2025
Mark Cuban
SuccessMark Cuban says his best investment of all time was still living like a student after college—including sleeping on the floor and driving a $200 broken car 
By Jessica CoacciSeptember 29, 2025
President Donald Trump smirks just off the camera in a black suit with a red tie.
EconomyAll bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
By Eva RoytburgSeptember 26, 2025
Photo: WASHINGTON, DC - SEPTEMBER 25: U.S. President Donald Trump speaks in the Oval Office of the White House on September 25, 2025 in Washington, DC. Trump signed several executive orders, including approving a partial sale of TikTok's U.S. operations, following a 2024 law requiring parent company ByteDance to divest or face a ban. (Photo by Andrew Harnik/Getty Images)
InvestingTrump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
By Jim EdwardsSeptember 26, 2025
Donald Trump
HealthScientists rebuke Trump’s Tylenol-autism claim, stress fever is bigger danger in pregnancy
By Jason Gale and BloombergSeptember 23, 2025
Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
North AmericaSwiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
By AFPSeptember 20, 2025
Ben Mabey stands on a stage with an opal-colored background.
InnovationThe AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits
By Sasha RogelbergSeptember 12, 2025
A new era of access demands smarter design for direct-to-consumer drug pricing
CommentaryA new era of access demands smarter design for direct-to-consumer drug pricing
By Wendy BarnesSeptember 5, 2025
Paul Hudson
CommentaryAI might beat IQ, not EQ — but never say never
By Paul HudsonSeptember 2, 2025
Trump’s plan for hefty tax on imported drugs risks higher prices and shortages
PoliticsTrump’s plan for hefty tax on imported drugs risks higher prices and shortages
By Paul Wiseman, Tom Murphy and The Associated PressSeptember 1, 2025
Ozempic
HealthNovo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By Nick LichtenbergAugust 18, 2025
AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
PoliticsAstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
By AFPJuly 22, 2025
Ireland sees thousands of jobs at risk from U.S. pharma tariffs
Workplace CultureIreland sees thousands of jobs at risk from U.S. pharma tariffs
By Olivia Fletcher, Stephen Carroll and BloombergJune 23, 2025
Bayer’s stock is charting a 40% rebound after years of losses
FinanceBayer’s stock is charting a 40% rebound after years of losses
By Isolde MacDonogh, Tim Loh and BloombergJune 18, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
...100
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Investing
Meet the 2 men putting New York's $300 billion pension fund in play for the first time in 20 yearsplaceholder alt text
By Nick LichtenbergJune 22, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.